45 results match your criteria: "Manchester Centre for Clinical Neuroscience[Affiliation]"

Article Synopsis
  • Motor neuron disease (MND), commonly known as amyotrophic lateral sclerosis (ALS), can be caused by genetic factors in some cases, primarily through autosomal dominant inheritance.
  • The demand for genetic testing and counselling is increasing among individuals affected by MND, but there are currently no established guidelines for predictive genetic testing in this area.
  • The paper discusses the genetic basis of MND, addresses its complex nature, and highlights the need for better understanding and support regarding the psychosocial impacts of genetic testing on patients and families.
View Article and Find Full Text PDF

Background: Rheumatoid arthritis (RA) patients are at heightened risk of Coronavirus Disease-19 (COVID-19) complications due to immune dysregulation, chronic inflammation, and treatment with immunosuppressive therapies. This study aims to characterize the clinical and laboratory parameters of RA patients diagnosed with COVID-19, identify predictive risk factors for severe forms of this infection for RA patients, and determine if any RA immunosuppressive therapy is associated with worse COVID-19 outcomes.

Methods: A retrospective observational case-control study included 86 cases (43 diagnosed with RA and 43 cases without any inflammatory or autoimmune disease) that suffered from SARS-CoV-2 in two Romanian hospitals between March 2020 and February 2024.

View Article and Find Full Text PDF

In recent years, there has been an observed increase in the frequency of cutaneous carcinoma, which correlates with sun exposure. This study aims to explore the variances of tumor characteristics and immune response markers among patients diagnosed with cutaneous squamous-cell carcinoma (SCC) and basosquamous-cell carcinoma (BSC) with varying levels of sun exposure. The objective is to elucidate the potential influence of sun exposure on tumor progression and immune response in these types of carcinomas.

View Article and Find Full Text PDF

Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis.

Neuromuscul Disord

May 2024

Manchester Centre for Clinical Neuroscience, Northern Care Alliance NHS Foundation Trust, Salford Royal, Stott Lane, Salford, M6 8HD, UK; The University of Manchester, Manchester Academic Health Science Centre, Core Technology Facility, Manchester, M13 9WU, UK.

Article Synopsis
  • Azathioprine is the first choice medicine for treating myasthenia gravis, but many people also use mycophenolate and methotrexate as alternatives.
  • A survey of 235 people found that azathioprine caused liver problems in 23% of users, mycophenolate led to diarrhea in 14%, and methotrexate made 18% feel tired.
  • Women generally have more side effects from these medicines, and azathioprine is often stopped more often than the other two due to these side effects, showing there’s a need for better treatments.
View Article and Find Full Text PDF

Delayed onset post-traumatic wound botulism.

Pract Neurol

July 2024

Neurology Department, Manchester Centre for Clinical Neuroscience, Northern Care Alliance NHS Foundation Trust, Salford, UK.

Article Synopsis
  • * His symptoms included severe eyelid drooping (ptosis), eye movement paralysis (ophthalmoplegia), and weakness in his neck and arms, alongside a recent arm fracture requiring amputation.
  • * After inconclusive tests and ongoing weakness despite treatment, they identified botulinum toxin too late for effective antitoxin; however, he eventually recovered well neurologically and no longer needed respiratory support.
View Article and Find Full Text PDF

Epidemiology of the idiopathic inflammatory myopathies.

Nat Rev Rheumatol

November 2023

Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

The idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of systemic autoimmune diseases that affect the skeletal muscles and can also involve the skin, joints, lungs and heart. The epidemiology of IIM is obscured by changing classification criteria and the inherent shortcomings of case identification using healthcare record diagnostic coding. The incidence of IIM is estimated to range from 0.

View Article and Find Full Text PDF

Objectives: To compare clinical characteristics, including the frequency of cutaneous, extramuscular manifestations and malignancy, between adults with anti-synthetase syndrome (ASyS) and DM.

Methods: Using data regarding adults from the MYONET registry, a cohort of DM patients with anti-Mi2/-TIF1γ/-NXP2/-SAE/-MDA5 autoantibodies, and a cohort of ASyS patients with anti-tRNA synthetase autoantibodies (anti-Jo1/-PL7/-PL12/-OJ/-EJ/-Zo/-KS) were identified. Patients with DM sine dermatitis or with discordant dual autoantibody specificities were excluded.

View Article and Find Full Text PDF

Nitrous oxide-induced myeloneuropathy: a case series.

J Neurol Neurosurg Psychiatry

September 2023

Barts Health NHS Trust, London, UK

Article Synopsis
  • - Nitrous oxide (NO) is a popular recreational drug among young adults in the UK, with neurological symptoms affecting users, though most existing data is from small studies.
  • - A study examined 119 patients with NO-related myeloneuropathy in major UK cities, finding that 85% presented with paraesthesia, especially in the lower limbs, and common symptoms included gait issues and bladder disturbances.
  • - The research indicates a link between the frequency of NO use and methylmalonic acid levels, suggesting a risk for neurological damage due to increased accessibility of NO canisters, emphasizing the need for greater awareness and early intervention.
View Article and Find Full Text PDF

Objective: Preoperative differentiation of facial nerve schwannoma (FNS) from vestibular schwannoma (VS) can be challenging, and failure to differentiate between these two pathologies can result in potentially avoidable facial nerve injury. This study presents the combined experience of two high-volume centers in the management of intraoperatively diagnosed FNSs. The authors highlight clinical and imaging features that can distinguish FNS from VS and provide an algorithm to help manage intraoperatively diagnosed FNS.

View Article and Find Full Text PDF

Real-World Data on Access to Standards of Care for People With Spinal Muscular Atrophy in the UK.

Front Neurol

May 2022

John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Spinal Muscular Atrophy (SMA) is characterized by muscle atrophy and weakness and has an incidence of 1:11. 000 live births which projects an estimated population in the UK of 650-1,300 affected patients. Standards of Care (SoC) were updated in 2017 and they have been widely adopted as a reference for implementation of care in SMA across the globe.

View Article and Find Full Text PDF

The perils of myositis mimickers with illustrative case reports.

Clin Exp Rheumatol

February 2022

National Institute for Health Research, Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, The University of Manchester; Department of Rheumatology, Salford Royal Hospital, Manchester Academic Health Science Centre, Salford; and Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester, UK.

Objectives: The idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of immune-mediated systemic disorders that commonly target skeletal muscles. The aim of our review is to remind clinicians to be vigilant of common mimickers, and what red flags to look for to avoid misdiagnosis.

Methods: We reviewed the clinical documentation and investigation results of illustrative real-life case examples of significant IIM mimickers with valuable learning points.

View Article and Find Full Text PDF

Objectives: We aimed to define the clinical and serological characteristics of pan-neurofascin antibody-positive patients.

Methods: We tested serum from patients with suspected immune-mediated neuropathies for antibodies directed against nodal/paranodal protein antigens using a live cell-based assay and solid-phase platform. The clinical and serological characteristics of antibody-positive and seronegative patients were then compared.

View Article and Find Full Text PDF

Objectives: Diagnosing the idiopathic inflammatory myopathies (IIMs) can be challenging as several conditions, including genetic myopathies such as limb girdle muscular dystrophy type R12 (LGMD 2 l, anoctaminopathy) mimic the presentation. Here we describe learning points identified from review of four patients with LGMD 2 l who were initially incorrectly diagnosed with IIM. Our aim is to provide clinicians working in adult rheumatology services with a toolkit to help identify non-inflammatory presentations of myopathy.

View Article and Find Full Text PDF

Perspectives on glucocorticoid usage in patients with adult inflammatory myopathy.

Clin Rheumatol

December 2021

National Institute for Health Research Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

This study aims to describe the patient perspective on glucocorticoid (GC) treatment and adverse effects (AEs) in idiopathic inflammatory myopathy (IIM). An online survey was distributed to patients with adult-onset IIM using the Myositis UK page on Healthunlocked.com, an online social network for health.

View Article and Find Full Text PDF

ABN news.

Pract Neurol

June 2021

Nuffield Department of Clinical Neurosciences, Oxford University, Oxford, UK.

View Article and Find Full Text PDF

Introduction: The aged brain frequently exhibits multiple pathologies, rather than a single hallmark pathology (pure pathology [PurP]), ranging from low/intermediate levels of additional pathology (LowP) to mixed severe pathology (mixed SevP). We investigated the frequency of PurP, LowP, and mixed SevP, and the impact of additional LowP on cognition.

Methods: Data came from 670 cases from the Brains for Dementia research program.

View Article and Find Full Text PDF

Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.

Rheumatology (Oxford)

July 2021

National Institute for Health Research Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

Objective: The current classification criteria for idiopathic inflammatory myopathy (IIM) retain PM as a major disease subgroup. However, evolution in the understanding of IIM has suggested that many of these patients could be better described as having an alternative diagnosis. In the present study, we apply the latest understanding of IIM subtyping to retrospectively review PM diagnoses in a large cohort of IIM patients.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigated the potential link between COVID-19 and Guillain-Barré syndrome (GBS) by analyzing GBS cases in the UK before and during the COVID-19 pandemic.
  • The researchers found that GBS incidence decreased during the pandemic and did not show a correlation with COVID-19 infection rates across different regions.
  • Although some GBS cases were associated with COVID-19, there were no significant differences in clinical features between COVID-19 positive and negative cases, suggesting no strong evidence linking the virus as a cause of GBS.
View Article and Find Full Text PDF